Daniel Abdun-nabi - Net Worth and Insider Trading
Daniel Abdun-nabi Net Worth
The estimated net worth of Daniel Abdun-nabi is at least $286,354 dollars as of 2024-04-16. Daniel Abdun-nabi is the CEO of Emergent BioSolutions Inc and owns about 144,553 shares of Emergent BioSolutions Inc (EBS) stock worth over $286,215. Daniel Abdun-nabi is also the Director of Aptevo Therapeutics Inc and owns about 178 shares of Aptevo Therapeutics Inc (APVO) stock worth over $139. Details can be seen in Daniel Abdun-nabi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Abdun-nabi has not made any transactions after 2019-06-25 and currently still holds the listed stock(s).
Transaction Summary of Daniel Abdun-nabi
Daniel Abdun-nabi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Abdun-nabi owns 3 companies in total, including Aptevo Therapeutics Inc (APVO) , Regenxbio Inc (RGNX) , and Emergent BioSolutions Inc (EBS) .
Click here to see the complete history of Daniel Abdun-nabi’s form 4 insider trades.
Insider Ownership Summary of Daniel Abdun-nabi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APVO | Aptevo Therapeutics Inc | 2019-06-25 | director |
| RGNX | Regenxbio Inc | 2016-08-05 | director |
| EBS | Emergent BioSolutions Inc | 2019-03-04 | director & President & COO |
Daniel Abdun-nabi Latest Holdings Summary
Daniel Abdun-nabi currently owns a total of 2 stocks. Among these stocks, Daniel Abdun-nabi owns 144,553 shares of Emergent BioSolutions Inc (EBS) as of March 4, 2019, with a value of $286,215 and a weighting of 99.95%. Daniel Abdun-nabi also owns 178 shares of Aptevo Therapeutics Inc (APVO) as of June 25, 2019, with a value of $139 and a weighting of 0.05%.
Latest Holdings of Daniel Abdun-nabi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2019-03-04 | 144,553 | 1.98 | 286,215 |
| APVO | Aptevo Therapeutics Inc | 2019-06-25 | 178 | 0.78 | 139 |
Holding Weightings of Daniel Abdun-nabi
Daniel Abdun-nabi Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Abdun-nabi has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 14,565 shares on March 4, 2019, which brought Daniel Abdun-nabi around $846,372.
According to the SEC Form 4 filings, Daniel Abdun-nabi has made a total of 1 transactions in Aptevo Therapeutics Inc (APVO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptevo Therapeutics Inc is the acquisition of 27 shares on June 25, 2019, which cost Daniel Abdun-nabi around $15,000.
Insider Trading History of Daniel Abdun-nabi
- 1
Daniel Abdun-nabi Trading Performance
GuruFocus tracks the stock performance after each of Daniel Abdun-nabi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Abdun-nabi is 1.96%. GuruFocus also compares Daniel Abdun-nabi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Abdun-nabi within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Abdun-nabi's insider trading performs compared to the benchmark.
Performance of Daniel Abdun-nabi
Average Relative Return
11.99%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 3.1 | 1.96 | 6.4 | 11.99 | 40.44 | 7.2 |
| Relative Return to S&P 500(%) | 1.78 | 0.16 | -2.85 | -0.73 | 26.39 | -1.39 |
Daniel Abdun-nabi Ownership Network
Ownership Network List of Daniel Abdun-nabi
Ownership Network Relation of Daniel Abdun-nabi
Daniel Abdun-nabi Owned Company Details
What does Aptevo Therapeutics Inc do?
Who are the key executives at Aptevo Therapeutics Inc?
Daniel Abdun-nabi is the director of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .
Aptevo Therapeutics Inc (APVO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aptevo Therapeutics Inc Insider Transactions
Daniel Abdun-nabi Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Abdun-nabi. You might contact Daniel Abdun-nabi via mailing address: 400 Professional Drive, Suite 400, Gaithersburg Md 20879.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
